Vituity Expands Partnership With Ascension at 21 Indiana Locations
05 avr. 2022 10h00 HE
|
Vituity
CHICAGO, April 05, 2022 (GLOBE NEWSWIRE) -- Vituity, a physician-led and -owned multispecialty healthcare company, is pleased to announce its expanded partnership with Ascension, including emergency...
Worldwide Ambulatory IV Infusion Pumps Industry to 2030 - Identify Growth Segments for Investment
24 mars 2022 05h48 HE
|
Research and Markets
Dublin, March 24, 2022 (GLOBE NEWSWIRE) -- The "Ambulatory IV Infusion Pumps Global Market Opportunities And Strategies To 2030, By Therapy, Patient Care Settings, Application" report has been added...
Vituity Expands Partnership With Sparrow Health System to Provide Emergency Care
22 mars 2022 10h00 HE
|
Vituity
EMERYVILLE, Calif., March 22, 2022 (GLOBE NEWSWIRE) -- Vituity, a physician-led and -owned multispecialty healthcare company, has expanded its partnership with Sparrow Health System to include...
CareCloud to Announce Fourth Quarter and Full Year 2021 Results on March 14, 2022
03 mars 2022 09h15 HE
|
CareCloud, Inc
SOMERSET, N.J., March 03, 2022 (GLOBE NEWSWIRE) -- CareCloud, Inc. (formerly MTBC, Inc., or the “Company”) (Nasdaq: MTBC, MTBCO, MTBCP), a leader in healthcare technology solutions for medical...
Sema4 to Participate at Two Upcoming Investor Conferences in February
03 févr. 2022 16h05 HE
|
Sema4
STAMFORD, Conn., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, today announced that company management will...
Sema4 to Acquire GeneDx, Strengthening its Market-Leading AI-Driven Genomic and Clinical Data Platform
18 janv. 2022 07h00 HE
|
Sema4
Business combination projected to deliver $350 million in pro forma 2022 revenue $200 million private placement from leading growth and life sciences investors, including Pfizer, will fortify...
Sema4 Announces Preliminary Revenue for the Fourth Quarter and Fiscal Year 2021
10 janv. 2022 07h15 HE
|
Sema4
STAMFORD, Conn., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, today announced preliminary revenue (unaudited) for the...
Sema4 to Participate at the 40th Annual J.P. Morgan Healthcare Conference in January
03 janv. 2022 16h05 HE
|
Sema4
STAMFORD, Conn., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, today announced that Eric Schadt, PhD, Founder and...
Rome Foundation Releases Clinical Criteria to Better Meet Needs of Patients
29 nov. 2021 09h00 HE
|
Rome Foundation
RALEIGH, N.C., Nov. 29, 2021 (GLOBE NEWSWIRE) -- The Rome Foundation has published a groundbreaking modification of the Rome IV diagnostic criteria of the Disorders of Gut Brain Interaction (DGBI -...
Palarum Smart Sock Fall Prevention Technology to Be Implemented at The Ohio State University Wexner Medical Center
29 nov. 2021 07h00 HE
|
Palarum, LLC
COLUMBUS, Ohio, Nov. 29, 2021 (GLOBE NEWSWIRE) -- The Ohio State University Wexner Medical Center will begin using Palarum's PUP® new smart sock technology at three of their hospitals in 2022. The...